MDS and MPN
SOHO 2022 Tenth Annual Meeting
SOHO 2022 Next Questions: Myeloproliferative Neoplasms
FEATURING
Srdan Verstovsek
- 66 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
Next Questions: Myelodysplastic Syndromes
FEATURING
Guillermo Garcia-Manero
- 185 views
- October 14, 2022
- 1
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Can Potential Disease Modifying Agents Change the Indication for Transplant in MPN?
FEATURING
Haris Ali
- 37 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
Novel Therapeutics in Development for Myelofibrosis
FEATURING
Srdan Verstovsek
- 143 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
Early Intervention in Myelofibrosis
FEATURING
Abdulraheem Yacoub
- 127 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Management of Prefibrotic Myelofibrosis
FEATURING
Prithviraj Bose
- 83 views
- October 14, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Magrolimab + Azacitidine for Patients With Untreated HR MDS - 5F9005 Phase 1b Study Results
FEATURING
David Sallman,
Naval Daver
- 72 views
- October 13, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Transplant in MDS
FEATURING
Ryotaro Nakamura
- 40 views
- October 13, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: BCL-2 Inhibition in MDS
FEATURING
Rami Komrokji,
Jacqueline Garcia
- 78 views
- October 13, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Immune Therapy Approaches in MDS
FEATURING
Jacqueline Garcia
- 28 views
- October 13, 2022
- 1
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Targeted Approaches in MDS
FEATURING
Lionel Adès
- 7 views
- October 13, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Molecular Classification of MDS
FEATURING
Luca Malcovati
- 23 views
- October 13, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Novel Therapies for ET
FEATURING
Laura Michaelis
- 49 views
- October 13, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Novel Therapies for PV
FEATURING
Lucia Masarova
- 125 views
- October 13, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Novel Therapies for Eosinophilia
FEATURING
Elizabeth Hexner
- 211 views
- October 13, 2022
- 1